[1]
|
Younossi, Z.M., Golabi, P., de Avila, L., Paik, J.M., Srishord, M., Fukui, N., et al. (2019) The Global Epidemiology of NAFLD and NASH in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Journal of Hepatology, 71, 793-801. https://doi.org/10.1016/j.jhep.2019.06.021
|
[2]
|
Tu, T. and Douglas, M.W. (2020) Hepatitis B Virus Infection: from Diagnostics to Treatments. Viruses, 12, Article No. 1366. https://doi.org/10.3390/v12121366
|
[3]
|
Grąt, K., Grąt, M. and Rowiński, O. (2020) Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines, 8, Article No. 298. https://doi.org/10.3390/biomedicines8090298
|
[4]
|
Huang, T.D., Behary, J. and Zekry, A. (2020) Non-Alcoholic Fatty Liver Disease: A Review of Epidemiology, Risk Factors, Diagnosis and Management. Internal Medicine Journal, 50, 1038-1047. https://doi.org/10.1111/imj.14709
|
[5]
|
Younossi, Z.M. (2019) Non-Alcoholic Fatty Liver Disease—A Global Public Health Perspective. Journal of Hepatology, 70, 531-544. https://doi.org/10.1016/j.jhep.2018.10.033
|
[6]
|
Fouad, Y., Waked, I., Bollipo, S., Gomaa, A., Ajlouni, Y. and Attia, D. (2020) What’s in a Name? Renaming ‘NAFLD’to ‘MAFLD’. Liver International, 40, 1254-1261. https://doi.org/10.1111/liv.14478
|
[7]
|
Yilmaz, Y., Byrne, C.D. and Musso, G. (2021) A Single-Letter Change in an Acronym: Signals, Reasons, Promises, Challenges, and Steps Ahead for Moving from NAFLD to MAFLD. Expert Review of Gastroenterology & Hepatology, 15, 345-352. https://doi.org/10.1080/17474124.2021.1860019
|
[8]
|
韩琳, 谢欢, 孙颖, 邹正升. 代谢相关脂肪性肝病的诊断与评估现状[J]. 肝脏, 2021, 26(2): 205-210.
|
[9]
|
Eslam, M., Newsome, P.N., Sarin, S.K., Anstee, Q.M., Targher, G., Romero-Gomez, M., et al. (2020) A New Definition for Metabolic Dysfunction-Associated Fatty Liver Disease: An International Expert Consensus Statement. Journal of Hepatology, 73, 202-209. https://doi.org/10.1016/j.jhep.2020.03.039
|
[10]
|
Eslam, M., Sanyal, A.J. and George, J. (2020) MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology, 158, 1999-2014.e1. https://doi.org/10.1053/j.gastro.2019.11.312
|
[11]
|
Barigou, M., Favre, L., Fraga, M. and Artru, F. (2020) New Trends in Non-Alcoholic Fatty Liver Diseases (NAFLD). Revue Médicale Suisse, 16, 586-591.
|
[12]
|
Shiha, G., Alswat, K., Al Khatry, M., Sharara, A.I. Örmeci, N., Waked, I., Benazzouz, M., et al. (2021) Nomenclature and Definition of Metabolic-Associated Fatty Liver Disease: A Consensus from the Middle East and North Africa. The Lancet Gastroenterology and Hepatology, 6, 57-64. https://doi.org/10.1016/S2468-1253(20)30213-2
|
[13]
|
范建高. 代谢相关脂肪性肝病现已成为我国第一大慢性肝病[J]. 中华医学信息导报, 2021, 36(6): 6.
|
[14]
|
Friedman, S.L., Neuschwander-Tetri, B.A., Rinella, M. and Sanyal, A.J. (2018) Mechanisms of NAFLD Development and Therapeutic Strategies. Nature Medicine, 24, 908-922. https://doi.org/10.1038/s41591-018-0104-9
|
[15]
|
Kuk, J.L., Saunders, T.J., Davidson, L.E. and Ross, R. (2009) Age-Related Changes in Total and Regional Fat Distribution. Ageing Research Reviews, 8, 339-48. https://doi.org/10.1016/j.arr.2009.06.001
|
[16]
|
Lonardo, A., Nascimbeni, F., Ballestri, S., Fairweather, D., Win, S., Than, T.A., et al. (2019) Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. Hepatology, 70, 1457-1469.
https://doi.org/10.1002/hep.30626
|
[17]
|
Rich, N.E., Oji, S., Mufti, A.R., Browning, J.D., Parikh, N.D., Odewole, M., et al. (2018) Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 16, 198-210.e2.
https://doi.org/10.1016/j.cgh.2017.09.041
|
[18]
|
Struben, V.M., Hespenheide, E.E. and Caldwell, S.H. (2000) Nonalcoholic Steatohepatitis and Cryptogenic Cirrhosis within Kindreds. The American Journal of Medicine, 108, 9-13. https://doi.org/10.1016/s0002-9343(99)00315-0
|
[19]
|
Yu, C., Xu, C., Xu, L., Yu, J., Miao, M. and Li, Y. (2012) Serum Proteomic Analysis Revealed Diagnostic Value of Hemoglobin for Nonalcoholic Fatty Liver Disease. Journal of Hepatology, 56, 241-247.
|
[20]
|
Lee, Y.J., Lee, H.R., Shim, J.Y., Moon, B.S., Lee, J.H. and Kim, J.K. (2010) Relationship between White Blood Cell Count and Nonalcoholic Fatty Liver Disease. Digestive and Liver Disease, 42, 888-894.
https://doi.org/10.1016/j.dld.2010.04.005
|
[21]
|
Frith, J., Jones, D. and Newton, J.L. (2009) Chronic Liver Disease in an Ageing Population. Age Ageing, 38, 11-18.
https://doi.org/10.1093/ageing/afn242
|
[22]
|
Papatheodoridi, A.M., Chrysavgis, L., Koutsilieris, M. and Chatzigeorgiou, A. (2020) The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis. Hepatology, 71, 363-374. https://doi.org/10.1002/hep.30834
|
[23]
|
Anderson, E.L., Howe, L.D., Jones, H.E., Higgins, J.P.T., Lawlor, D.A. and Fraser, A. (2015) The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLoS ONE, 10, Article ID: e0140908. https://doi.org/10.1371/journal.pone.0140908
|
[24]
|
Zhou, F., Zhou, J., Wang, W., Zhang, X.J., Ji, Y.X., Zhang, P., et al. (2019) Unexpected Rapid Increase in the Burden of NAFLD in China from 2008 to 2018: A Systematic Review and Meta-Analysis. Hepatology, 70, 1119-1133.
https://doi.org/10.1002/hep.30702
|
[25]
|
Shen, J., Wong, G.L., Chan, H.L., Chan, H.Y., Yeung, D.K., Chan, R.S., et al. (2014) PNPLA3 Gene Polymorphism Accounts for Fatty Liver in Community Subjects Without Metabolic Syndrome. Alimentary Pharmacology & Therapeutics, 39, 532-539. https://doi.org/10.1111/apt.12609
|
[26]
|
Guthold, R., Stevens, G.A., Riley, L.M. and Bull, F.C. (2018) Worldwide Trends in Insufficient Physical Activity from 2001 to 2016: A Pooled Analysis of 358 Population-Based Surveys with 1.9 Million Participants. The Lancet Global Health, 6, E1077-E1086. https://doi.org/10.1016/s2214-109x(18)30357-7
|
[27]
|
Bambha, K., Belt, P., Abraham, M., Wilson, L.A., Pabst, M., Ferrell, L., et al. (2012) Ethnicity and Nonalcoholic Fatty Liver Disease. Hepatology, 55, 769-780. https://doi.org/10.1002/hep.24726
|
[28]
|
Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., et al. (2017) Gut Microbiome-Based Metagenomic Signature for Non-Invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metabolism, 25, 1054-1062.e5. https://doi.org/10.1016/j.cmet.2017.04.001
|
[29]
|
Caussy, C. and Loomba, R. (2018) Gut Microbiome, Microbial Metabolites and the Development of NAFLD. Nature Reviews Gastroenterology & Hepatology, 15, 719-720. https://doi.org/10.1038/s41575-018-0058-x
|
[30]
|
Arab, J.P., Karpen, S.J., Dawson, P.A., Arrese, M. and Trauner, M. (2017) Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives. Hepatology, 65, 350-362. https://doi.org/10.1002/hep.28709
|
[31]
|
Romero-Gómez, M., Zelber-Sagi, S. and Trenell, M. (2017) Treatment of NAFLD with Diet, Physical Activity and Exercise. Journal of Hepatology, 67, 829-846. https://doi.org/10.1016/j.jhep.2017.05.016
|
[32]
|
Trovato, F.M., Catalano, D., Martines, G.F., Pace, P. and Trovat,o G.M. (2015) Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: The Need of Extended and Comprehensive Interventions. Clinical Nutrition, 34, 86-88.
https://doi.org/10.1016/j.clnu.2014.01.018
|
[33]
|
Barata, L., Feitosa, M.F., Bielak, L.F., Halligan, B., Baldridge, A.S., Guo, X., et al. (2019) Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals without Diabetes. Hepatology Communications, 3, 894-907. https://doi.org/10.1002/hep4.1353
|
[34]
|
Yoneda, M., Yamamoto, T., Honda, Y., Imajo, K., Ogawa, Y., Kessoku, T., et al. (2021) Risk of Cardiovascular Disease in Patients with Fatty Liver Disease As Defined from the Metabolic Dysfunction Associated Fatty Liver Disease Or Nonalcoholic Fatty Liver Disease Point of View: A Retrospective Nationwide Claims Database Study in Japan. Journal of Gastroenterology, 56, 1022-1032. https://doi.org/10.1007/s00535-021-01828-6
|
[35]
|
Lin, S., Huang, J., Wang, M., Kumar, R., Liu, Y., Liu, S., et al. (2020) Comparison of MAFLD and NAFLD Diagnostic Criteria in Real World. Liver International, 40, 2082-2089. https://doi.org/10.1111/liv.14548
|
[36]
|
Li, H., Guo, M., An, Z., Meng, J., Jiang, J., Song, J., et al. (2020) Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China. International Journal of Environmental Research and Public Health, 17, Article No. 1818. https://doi.org/10.3390/ijerph17061818
|
[37]
|
Kwon, Y.M., Oh, S.W., Hwang, S.S., Lee, C., Kwon, H. and Chung, G.E. (2012) Association of Nonalcoholic Fatty Liver Disease with Components of Metabolic Syndrome According to Body Mass Index in Korean Adults. The American Journal of Gastroenterology, 107, 1852-1858. https://doi.org/10.1038/ajg.2012.314
|
[38]
|
Zhang, H.J., He, J., Pan, L.L., Ma, Z.M., Han, C.K., Chen, C.S., et al. (2016) Effects of Moderate and Vigorous Exercise On Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial. JAMA Internal Medicine, 176, 1074-1082.
https://doi.org/10.1001/jamainternmed.2016.3202
|
[39]
|
蔡联英, 王文娟, 梁运啸, 宋怀宇. 代谢相关脂肪性肝病与代谢综合征相关性的研究进展[J]. 中国临床新医学, 2021, 14(7): 730-734.
|
[40]
|
Yilmaz, Y., Senates, E., Ayyildiz, T., Colak, Y., Tuncer, I., Ovunc, A.O.K., et al. (2012) Characterization of Nonalcoholic Fatty Liver Disease Unrelated to the Metabolic Syndrome. European Journal of Clinical Investigation, 42, 411-418. https://doi.org/10.1111/j.1365-2362.2011.02597.x
|
[41]
|
Akyuz, U., Yesil, A. and Yilmaz, Y. (2015) Characterization of Lean Patients with Nonalcoholic Fatty Liver Disease: Potential Role of High Hemoglobin Levels. Scandinavian Journal of Gastroenterology, 50, 341-346.
https://doi.org/10.3109/00365521.2014.983160
|
[42]
|
Yilmaz, Y. (2012) NAFLD in the Absence of Metabolic Syndrome: Different Epidemiology, Pathogenetic Mechanisms, Risk Factors for Disease Progression? Seminars in Liver Disease, 32, 14-21.
https://doi.org/10.1055/s-0032-1306422
|
[43]
|
Xu, L., Xu, C.F., Yu, C.H., Miao, M. and Li, Y.M. (2009) Haemoglobin and Non-Alcoholic Fatty Liver Disease: Further Evidence from a Population-Based Study. Gut, 58, 1706-1707. https://doi.org/10.1136/gut.2009.186668
|
[44]
|
Wang, S., Zhang, C., Zhang, G., Yuan, Z., Liu, Y., Ding, L., et al. (2016) Association between White Blood Cell Count and Non-Alcoholic Fatty Liver Disease in Urban Han Chinese: A Prospective Cohort Study. BMJ Open, 6, Article ID: E010342.
|
[45]
|
Ryu, S., Chang, Y., Kim, S.G., Cho, J and Guallar, E. (2011) Serum Uric Acid Levels Predict Incident Nonalcoholic Fatty Liver Disease in Healthy Korean Men. Metabolism, 60, 860-866. https://doi.org/10.1016/j.metabol.2010.08.005
|
[46]
|
Liu, C.Q., He, C.M., Chen, N., Wang, D., Shi, X., Liu, Y., et al. (2016) Serum Uric Acid Is Independently and Linearly Associated with Risk of Nonalcoholic Fatty Liver Disease in Obese Chinese Adults. Scientific Reports, 6, Article No. 38605. https://doi.org/10.1038/srep38605
|
[47]
|
Wei, F., Li, J., Chen, C., Zhang, K., Cao, L., Wang, X., et al. (2020) Higher Serum Uric Acid Level Predicts Non-Alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study. Frontiers in Endocrinology, 11, Article No. 179. https://doi.org/10.3389/fendo.2020.00179
|